Best Practice & Research Clinical Rheumatology
Volume 23, Issue 4 , Pages 575-582, August 2009

Managing lupus patients during pregnancy

  • Guillermo Ruiz-Irastorza, MD, PhD, Doctor

      Affiliations

    • Service and Department of Internal Medicine, Hospital De Cruces, University of the Basque Country, Bizkaia, Spain
  • ,
  • Munther A. Khamashta, MD, FRCP, PhD, Doctor

      Affiliations

    • Lupus Research Unit, The Rayne Institute, St. Thomas' Hospital, King's College, London SE1 7EH, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 20 7620 2567; Fax: +44 20 7620 26 58.

Pregnancy still constitutes a major challenge for women with systemic lupus erythematosus. Coordinated medical/obstetric care is essential to maximise the chance of success. Pregnancy should be planned in advance, following a pre-conceptional visit in which the specific risk for complications can be assessed. Previous complicated pregnancies, renal disease, irreversible damage, anti-phospholipid antibodies and treatment with high-dose steroids are adverse features. Pregnancy should be discouraged in women with symptomatic pulmonary hypertension, heart failure, severe restrictive pulmonary disease, severe chronic renal failure and recent serious lupus activity. Treatment is based on hydroxychloroquine, low-dose steroids, azathioprine and in patients with anti-phospholipid antibodies, low-dose aspirin±low molecular weight heparin. Close surveillance, with monitoring of blood pressure, proteinuria and placental blood flow by Doppler studies helps the early diagnosis and treatment of complications such as pre-eclampsia and foetal distress. Post-partum follow-up is also essential.

Keywords: systemic lupus erythematosus, anti-cardiolipin, lupus anticoagulant, miscarriage, foetal death, pre-eclampsia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-6942(09)00045-X

doi:10.1016/j.berh.2009.04.004

Best Practice & Research Clinical Rheumatology
Volume 23, Issue 4 , Pages 575-582, August 2009